Ankura is pleased to present an overview of healthcare transactions announced or closed during Q1 2024 in the United States. Total transactions decreased by 7.6% in the first quarter of 2024 after remaining relatively flat in the fourth quarter of 2023. Excluding the Life Sciences and Medical Office Buildings sectors, the total number of transactions in the United States decreased by 12.1%. The notable decrease in acquisition activity in the first quarter of 2024 marks the lowest number of announced transactions for the healthcare industry since Q4 2020. Despite previous optimism that healthcare transaction activity would rebound from the declines seen in 2023, the industry faced a slower start to the year as a result of ongoing downward pressure, including continued high interest rates and intensified regulatory scrutiny.
Read the full article: Quarterly Healthcare Transactions Review: Unveiling the Latest Industry Mergers and Acquisitions [Q1 2024] //
Source: https://angle.ankura.com/post/102j74c/quarterly-healthcare-transactions-review-unveiling-the-latest-industry-mergers-a